Release Date: 16/03/17 18:36 Summary: Change of Director's Interest Notice Price Sensitive: No Download Document 34.39KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%